SCHEMBL7130416

SCHEMBL7130416

C[C@@H](Oc1ccc2c(c1)S(=O)(=O)N=C(c1c(O)c3cccnc3n(CCC3CC3)c1=O)N2)C(N)=O

nearest known ligand 0.73

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.73
NR1I2 O75469 1/20 0.50
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37
CNR2 P34972 7/20 0.36
CNR1 P21554 5/20 0.36
HIF1A Q16665 1/20 0.31
PIK3CA P42336 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7130420 1.00 CYP2C9 (0.73) CYP2C9NR1I2MAPK1HSD17B10HTR3E
SCHEMBL7077611 0.90 CYP2C9 (0.59) CYP2C9NR1I2MAPK1HSD17B10HTR3E
SCHEMBL7075766 0.89 CYP2C9 (0.73) CYP2C9NR1I2MAPK1HSD17B10HTR3E
SCHEMBL6231450 0.84 CYP2C9 (1.00) CYP2C9NR1I2MAPK1HSD17B10CNR2
SCHEMBL6738653 0.84 CYP2C9 (1.00) CYP2C9NR1I2MAPK1HSD17B10CNR2
SCHEMBL1522705 0.81 CYP2C9 (0.56) CYP2C9NR1I2MAPK1HSD17B10
SCHEMBL1522557 0.80 MAPK1 (0.50) CYP2C9NR1I2MAPK1HSD17B10
SCHEMBL1522570 0.80 MAPK1 (0.48) CYP2C9NR1I2MAPK1HSD17B10HTR3E
SCHEMBL1522875 0.80 MAPK1 (0.48) CYP2C9NR1I2MAPK1HSD17B10HTR3E
SCHEMBL1523042 0.79 CYP2C9 (0.47) CYP2C9NR1I2MAPK1HSD17B10HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059356-A2 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2003-07-24 WO disclosed